Regimens for treating HIV infections and aids
US12178815B2 · kind B2 · utility
0Cited by
1References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 3, 2024 |
| Grant date | Dec 31, 2024 |
| Priority date | — |
| Expiry date | Jul 3, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.